InsidersTradesSigma
BioPorto A/S Stock: price and directors' dealings · Denmark · Finanstilsynet DK
Follow the BioPorto A/S stock price and the full insider trade history of the company, a publicly traded company based in Denmark. Shares are listed on DK DK, under the supervision of Finanstilsynet DK. Operating in the Health Care sector, BioPorto A/S has logged 30 reports. Market capitalisation: €604m. The latest transaction was disclosed on 24 November 2025 (Subscription). Among the most active insiders: Unknown. The full history is openly available.
30
Insider Decl.
0
Thresholds
€30m
6 ops.
Buy Volume
€3m
1 ops.
Sell Volume
35Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,476 of 26,134 companies
29.1
score / 100
Value13
Quality45
FCF yld-14%
Earn yld-15%
EV/EBITDA·
ROE-126%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 November 2025
Declarations30 total
72 shares@ DKK 1.000.066% mcap1.2% of flowShareOutside a trading venueDK:1402296
60,227 shares@ DKK 378.000.51% mcap9.2% of flowShareNasdaq Copenhagen A/S, XCSEDK:1034031
150,000 shares@ DKK 397.001.32% mcap24.1% of flowShareOutside a trading venueDK:895526
254,453 shares@ DKK 393.002.22% mcap40.5% of flowShareOutside a trading venueDK:863196
100,000 shares@ DKK 306.000.68% mcap12.4% of flowShareNasdaq Copenhagen A/S, XCSEDK:786557
Ideal exit: 7 May 2018 (T+270)
100,000 shares@ DKK 306.000.68% mcap12.4% of flowShareOutside a trading venueDK:786547
Ideal exit: 7 May 2018 (T+270)
100,000 shares@ DKK 1.690.0038% mcap0.1% of flowShareoutside a trading venueDK:745848
Ideal exit: 11 Aug 2017 (T+270)
ShareDK:705282
ShareDK:705009
ShareDK:600799
ShareDK:572761
ShareDK:570338
ShareDK:569444
ShareDK:519037
ShareDK:447753
ShareDK:393305
ShareDK:331795
ShareDK:330179
ShareDK:328925
ShareDK:320054
ShareDK:318634
ShareDK:318294
ShareDK:317962
ShareDK:317733
ShareDK:305261
25 of 30 declarations
About BioPorto A/S
BioPorto A/S is a Danish company specializing in the development of medical diagnostics. It focuses on innovative tests for serious diseases, particularly kidney disorders.